Conference
A randomized phase II study of OGX-011 in combination with docetaxel and prednisone or docetaxel and prednisone alone in patients with metastatic hormone refractory prostate cancer (HRPC)
Authors
Chi KN; Hotte SJ; Yu E; Eigl BJ; Tannock I; Saad F; North S; Powers J; Eisenhauer E
Volume
25
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
June 20, 2007
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
18
ISSN
0732-183X